TSG ADVOCATES DC, LLC

Lobbying for MOUNTAINSTAR CAPITAL, LLC · Investors in the healthcare industry and real estate

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate · $30,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Advancing research discoveries on ultra-rare pediatric neurodegenerative diseases, specifically BPAN (Beta-Propeller Protein- Associated Neurodegeneration) caused by a mutation in the WDR45 gene.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.